Wednesday, June 7, 2017
- 1:15pm-2:45pm
-
Effects of continuous apomorphine infusion on motor and nonmotor symptoms in Parkinson’s disease without cognitive deterioration
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Effects of dopaminergic medication on executive function in Parkinson’s disease differs according to the clinical stage
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Effects of education level on motor and non-motor symptoms of Brazilian patients with Parkinson’s disease.
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Effects of TRH therapy on the prism adaptation task in patients with spinocerebellar degeneration.
Neurophysiology (Non-PD) · Exhibit Hall C
- 1:15pm-2:45pm
-
Effects of zonisamide, an anti-parkinsonian drug, on cognition and BPSD in DLB patients: A post-hoc analysis of DLB Ph2 study
Cognitive Disorders · Exhibit Hall C
- 1:15pm-2:45pm
-
Efficacy of IncobotulinumtoxinA for the Treatment Of Shoulder Spasticity
Spasticity · Exhibit Hall C
- 1:15pm-2:45pm
-
Efficacy of IncobotulinumtoxinA in Treatment of Lower Limb Spasticity in Adults
Spasticity · Exhibit Hall C
- 1:15pm-2:45pm
-
Electrophysiological markers for emotional and cognitive impairment in Parkinson’s disease
Parkinson's Disease: Psychiatric Manifestations · Exhibit Hall C
- 1:15pm-2:45pm
-
Emotion regulation and neuropsychological status in psychogenic subtypes.
Cognitive Disorders · Exhibit Hall C
- 1:15pm-2:45pm
-
Event-related potentials and mild cognitive impairment in Parkinson’s disease.
Parkinson's Disease: Cognition · Exhibit Hall C
- «Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 38
- Next Page»